Clinical Trial Update: Expanded Access Protocol for Patients With Eosinophilic Esophagitis

View source ↗

Summary

Expanded access protocol for eosinophilic esophagitis sponsored by Ellodi Pharmaceuticals is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Snippet

Sponsor: Ellodi Pharmaceuticals, LP | Conditions: Eosinophilic Esophagitis | Status: NO_LONGER_AVAILABLE